Medigene with strong impulseIs medigene breaking out of trendchannel or simply overbought right now. CRS and RSI strong.
Came out of a bollinger squeeze and rising.
How can you tell if its a breakout from trend? Will it continue or fall back?
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.230EUR
−16.18 MEUR
6.03 MEUR
6.92 M
About MEDIGENE AG
Sector
Industry
CEO
Selwyn Ho
Website
Headquarters
Martinsried
Employees (FY)
86
Founded
1996
ISIN
DE000A40ESG2
FIGI
BBG00HMXV3D0
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.
An aggregate view of professional's ratings.
Frequently Asked Questions
The current price of MDG2 is 2.155 EUR — it has decreased by −0.23% in the past 24 hours. Watch MEDIGENE AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange MEDIGENE AG stocks are traded under the ticker MDG2.
MDG2 stock has risen by 12.59% compared to the previous week, the month change is a −6.30% fall, over the last year MEDIGENE AG has showed a −6.30% decrease.
We've gathered analysts' opinions on MEDIGENE AG future price: according to them, MDG2 price has a max estimate of 6.00 EUR and a min estimate of 6.00 EUR. Watch MDG2 chart and read a more detailed MEDIGENE AG stock forecast: see what analysts think of MEDIGENE AG and suggest that you do with its stocks.
MDG2 reached its all-time high on Aug 29, 2024 with the price of 2.300 EUR, and its all-time low was 1.705 EUR and was reached on Sep 4, 2024. View more price dynamics on MDG2 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MDG2 stock is 0.23% volatile and has beta coefficient of 0.70. Track MEDIGENE AG stock price on the chart and check out the list of the most volatile stocks — is MEDIGENE AG there?
Today MEDIGENE AG has the market capitalization of 15.59 M, it has increased by 21.09% over the last week.
Yes, you can track MEDIGENE AG financials in yearly and quarterly reports right on TradingView.
MEDIGENE AG is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
MDG2 earnings for the last half-year are −0.52 EUR per share, whereas the estimation was −0.56 EUR, resulting in a 7.14% surprise. The estimated earnings for the next half-year are −0.38 EUR per share. See more details about MEDIGENE AG earnings.
MEDIGENE AG revenue for the last half-year amounts to 4.48 M EUR, despite the estimated figure of 4.15 M EUR. In the next half-year revenue is expected to reach 6.52 M EUR.
MDG2 net income for the last half-year is −6.73 M EUR, while the previous report showed −9.21 M EUR of net income which accounts for 26.95% change. Track more MEDIGENE AG financial stats to get the full picture.
No, MDG2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2024, the company has 86.00 employees. See our rating of the largest employees — is MEDIGENE AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGENE AG EBITDA is −14.26 M EUR, and current EBITDA margin is −249.04%. See more stats in MEDIGENE AG financial statements.
Like other stocks, MDG2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGENE AG stock right from TradingView charts — choose your broker and connect to your account.